SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

 

Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

 

For the month of May 2026

 

Commission file number: 001-32749

 

FRESENIUS MEDICAL CARE AG

(Translation of registrant's name into English)

 

Else-Kröner Strasse 1

61346 Bad Homburg

Germany

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x                Form 40-F ¨

 

 

EXHIBITS

 

The following exhibits are being furnished with this Report:

 

Exhibit 99.1	Press Release issued on May 21, 2026.
Exhibit 99.2	Convenience translation of the Notice pursuant to Section 49(1), sentence 1, no. 2 of the German Securities Trading Act (WpHG) (Resolution on an authorization to exclude subscription rights in connection with the use of treasury shares).
Exhibit 99.3	Convenience translation of the Notice pursuant to Section 49(1), sentence 1, no. 2 of the WpHG (Resolution on the cancellation of treasury shares for the purpose of reducing the share capital).
Exhibit 99.4	Press Release issued on May 26, 2026.
	This disclosure does not constitute an offer to purchase or a solicitation of any offer to sell any securities.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

DATE: May 26, 2026

 

	Fresenius Medical Care AG
	By:	/s/ Helen Giza
	Name:	Helen Giza
	Title:	Chief Executive Officer and Chair of the Management Board
	By:	/s/ Martin Fischer
	Name:	Martin Fischer
	Title:	Chief Financial Officer and member of the Management Board

 

 

ATTACHMENTS / EXHIBITS

EXHIBIT 99.1

EXHIBIT 99.2

EXHIBIT 99.3

EXHIBIT 99.4

SEC Filings